Stempeutics gets patent for stem cell drug Stempeucel from US Patent and Trademarks Office Medical Dialogues Bureau3 Nov 2019 9:55 AM IST"The US patent is for the method of treating ischemia by administering pooled allogeneic mesenchymal stromal cells," Stempeutics Research said in a...
DCGI grants limited approval to market Stempeucel® product for treating Critical Limb Ischemia due to Buerger's disease Geeta Sharma Sharma4 Jun 2016 1:21 PM ISTStempeutics Research, a group company of Manipal Education & Medical Group and a joint venture with Cipla Group, announced today that the Drugs...